0001437749-24-019713.txt : 20240607
0001437749-24-019713.hdr.sgml : 20240607
20240607171323
ACCESSION NUMBER: 0001437749-24-019713
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240606
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Rajiv
CENTRAL INDEX KEY: 0001642407
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34475
FILM NUMBER: 241030640
MAIL ADDRESS:
STREET 1: C/O ARCADIA BIOSCIENCES, INC.
STREET 2: 202 COUSTEAU PLACE, SUITE 105
CITY: DAVIS
STATE: CA
ZIP: 95618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OMEROS CORP
CENTRAL INDEX KEY: 0001285819
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 911663741
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 ELLIOTT AVENUE WEST
CITY: SEATTLE
STATE: WA
ZIP: 98119
BUSINESS PHONE: 206-676-5000
MAIL ADDRESS:
STREET 1: 201 ELLIOTT AVENUE WEST
CITY: SEATTLE
STATE: WA
ZIP: 98119
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-06-06
0001285819
OMEROS CORP
OMER
0001642407
Shah Rajiv
201 ELLIOTT AVENUE WEST
SEATTLE
WA
98119
1
0
Stock Option (Right to Buy)
3.91
2024-06-06
4
A
0
15000
0
A
2034-06-06
Common Stock
15000
15000
D
Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 6, 2024.
This option will fully vest and become exercisable on the day before the date of the 2025 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.
/s/ Peter B. Cancelmo, Attorney-in-Fact
2024-06-07